Jazz Pharmaceuticals(JAZZ) - 2024 Q1 - Earnings Call Presentation

May 1, 2024 2024 First Quarter Financial Results Innovating to Transform the Lives of Patients and Their Families Caroline Rylaze® patient diagnosed with ALL / LBL May 1, 2024 Transforming Lives. Redefining Possibilities. Caution Concerning Forward-Looking Statements This presentation contains forward-looking statements and financial targets, including, but not limited to, statements related to: the Company’s growth prospects and future financial and operating results, including the Company’s 2024 financial ...